Tenaya Therapeutics Q3 EPS $(0.08) Beats $(0.10) Estimate, Sales $1.697M Beat $800.000K Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. This is a 33.33 percent increase over losses of $(0.12) per share from
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $1.697 million which beat the analyst consensus estimate of $800.000 thousand by 112.13 percent.